Epidemiology and characteristics of adverse drug reactions caused by drug–drug interactions

Bibliography

• Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000;356:1255-9
   PubMed Web of Science ®Google Scholar
• Aronson JK. Classifying drug interactions. Br J Clin Pharmacol 2004;58:343-4
   PubMed Web of Science ®Google Scholar
• Baxter K. Stockley's Drug Interactions. Pharmaceutical Press; London: 2008
   Google Scholar
• Kohler GI, Bode-Boger SM, Busse R, Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use. Int J Clin Pharmacol Ther 2000;38:504-13
   PubMed Web of Science ®Google Scholar
• Bjerrum L, Andersen M, Petersen G, Kragstrup J. Exposure to potential drug interactions in primary health care. Scand J Prim Health Care 2003;21:153-8
   PubMed Web of Science ®Google Scholar
• Astrand B, Astrand E, Antonov K, Petersson G. Detection of potential drug interactions - a model for a national pharmacy register. Eur J Clin Pharmacol 2006;62:749-56
   PubMed Web of Science ®Google Scholar
• Buurma H, De Smet PAGM, Egberts ACG. Clinical risk management in Dutch community pharmacies: the case of drug-drug interactions. Drug Saf 2006;29:723-32
   PubMed Web of Science ®Google Scholar
• Fux R, Greiner D, Geldmacher M, Multiple drug prescribing by general practitioners in a German region: implications for drug interactions and patient safety. Int J Clin Pharmacol Ther 2006;44:539-47
   PubMed Web of Science ®Google Scholar
• Straubhaar B, Krahenbuhl S, Schlienger RG. The prevalence of potential drug-drug interactions in patients with heart failure at hospital discharge. Drug Saf 2006;29:79-90
   PubMed Web of Science ®Google Scholar
• Doubova SV, Reyes-Morales H, LdelP T-A, Suarez-Ortega M. Potential drug-drug and drug-disease interactions in prescriptions for ambulatory patients over 50 years of age in family medicine clinics in Mexico City. BMC Health Serv Res 2007; published online 19 September 2007; doi:10.1186/1472-6963-7-147
   Web of Science ®Google Scholar
• Vonbach P, Dubied A, Krahenbuhl S, Beer JH. Prevalence of drug-drug interactions at hospital entry and during hospital stay of patients in internal medicine. Eur J Intern Med 2008;19:413-20
   PubMed Web of Science ®Google Scholar
• Reimche L, Forster AJ, van Walraven C. Incidence and contributors to potential drug-drug interactions in hospitalized patients. J Clin Pharmacol 2010; published online 6 October 2010; doi:10.1177/0091270010378858
   PubMed Web of Science ®Google Scholar
• Smithburger PL, Kane-Gill SL, Seybert AL. Drug-drug interactions in cardiac and cardiothoracic intensive care units: an analysis of patients in an academic medical centre in the US. Drug Saf 2010;33:879-88
   PubMed Web of Science ®Google Scholar
• Doucet J, Chassagne P, Trivalle C, Drug-drug interactions related to hospital admissions in older adults: a prospective study of 1000 patients. J Am Geriatr Soc 1996;44:944-8
   PubMed Web of Science ®Google Scholar
• Lindley CM, Tully MP, Paramsothy V, Tallis RC. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992;21:294-300
   PubMed Web of Science ®Google Scholar
• Tirkkonen T, Ryynanen A, Vahlberg T, Frequency and clinical relevance of drug interactions with lovastatin and simvastatin: an observational database study. Drug Saf 2008;31:231-40
   PubMed Web of Science ®Google Scholar
• Gruer PJ, Vega JM, Mercuri MF, Concomitant use of cytochrome P450 3A4 inhibitors and simvastatin. Am J Cardiol 1999;84:811-15
   PubMed Web of Science ®Google Scholar
• Fokter N, Mozina M, Brvar M. Potential drug-drug interactions and admissions due to drug-drug interactions in patients treated in medical departments. Wien Klin Wochenschr 2010;122:81-8
   PubMed Web of Science ®Google Scholar
• Juurlink DN, Mamdani M, Kopp A, Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 2003;289:1652-8
   PubMed Web of Science ®Google Scholar
• Ducharme MM, Boothby LA. Analysis of adverse drug reactions for preventability. Int J Clin Pract 2007;61:157-61
   PubMed Web of Science ®Google Scholar
• Glassman PA, Belperio P, Lanto A, The utility of adding retrospective medication profiling to computerized provider order entry in an ambulatory care population. J Am Med Inform Assoc 2007;14:424-31
   PubMed Web of Science ®Google Scholar
• Dennehy CE, Kishi DT, Louie C. Drug-related illness in emergency department patients. Am J Health Syst Pharm 1996;53:1422-6
   PubMed Web of Science ®Google Scholar
• Malhotra S, Jain S, Pandhi P. Drug-related visits to the medical emergency department: a prospective study from India. Int J Clin Pharmacol Ther 2001;39:12-18
   PubMed Web of Science ®Google Scholar
• Prince BS, Goetz CM, Rihn TL, Drug-related emergency department visits and hospital admissions. Am J Hosp Pharm 1992;49(7):1696-700
   PubMedGoogle Scholar
• Raschetti R, Morgutti M, Menniti-Ippolito F, Suspected adverse drug events requiring emergency department visits or hospital admissions. Eur J Clin Pharmacol 1999;54:959-63
   PubMed Web of Science ®Google Scholar
• Schneitman-McIntire O, Farnen TA, Gordon N, Medication misadventures resulting in emergency department visits at and HMO medical center. Am J Health Syst Pharm 1996;53(12):1416-22
   PubMed Web of Science ®Google Scholar
• Bhalla N, Duggan C, Dhillon S. The incidence and nature of drug-related admissions to hospital. Pharmaceutical J 2003;270:583-6
   Google Scholar
• Dormann H, Criegee-Rieck M, Neubert A, Lack of awareness of community-acquired adverse drug reactions upon hospital admission: dimensions and consequences of a dilemma. Drug Saf 2003;26(5):353-62
   PubMed Web of Science ®Google Scholar
• Hallas J, Harvald B, Gram LF, Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med 1990;228(2):83-90
   PubMed Web of Science ®Google Scholar
• Hallas J, Gram LF, Grodum E, Drug related admissions to medical wards: a population based survey. Br J Clin Pharmacol 1992;33:61-8
   PubMed Web of Science ®Google Scholar
• Huic M, Mucolic V, Vrhovac B, Adverse drug reactions resulting in hospital admission. Int J Clin Pharmacol Ther 1994;32(12):675-82
   PubMed Web of Science ®Google Scholar
• McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 2002;36:1331-6
   PubMed Web of Science ®Google Scholar
• Mok H, Mulpeter K, O'Connor P, Drug-drug interactions in hospital. Ir Med J 1991;84(1):26
   PubMedGoogle Scholar
• Peyriere H, Cassan S, Floutard E, Adverse drug events associated with hospital admission. Ann Pharmacother 2003;37:5-11
   PubMed Web of Science ®Google Scholar
• Pirmohamed M, James S, Meakin S, Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004;329:15-19
   PubMed Web of Science ®Google Scholar
• Stanton LA, Peterson GM, Rumble RH, Drug-related admissions to an Australian hospital. J Clin Pharm Ther 1994;19(6):341-7
   PubMed Web of Science ®Google Scholar
• Courtman BJ, Stallings SB. Characterization of drug-related problems in elderly patients on admission to a medical ward. Can J Hosp Pharm 1995;48:161-6
   PubMedGoogle Scholar
• Easton KL, Chapman CB, Brien JA. Frequency and characteristics of hospital admissions associated with drug-related problems in paediatrics. Br J Clin Pharmacol 2004;57:611-15
   PubMed Web of Science ®Google Scholar
• Miranda V, Fede A, Nobuo M, Adverse drug reactions and drug interactions as causes of hospital admission in oncology. J Pain Symptom Manage 2011; published online 31 March 2011; doi:10.1016/j.jpainsymman.2010.11.014
   PubMed Web of Science ®Google Scholar
• Rivkin A. Admissions to a medical intensive care unit related to adverse drug reactions. Am J Health Syst Pharm 2007;64:1840-3
   PubMed Web of Science ®Google Scholar
• Davies EC, Green CF, Mottram DR, Emergency re-admissions to hospital due to adverse drug reactions within 1 year of the index admission. Br J Clin Pharmacol 2010;70:749-55
   PubMed Web of Science ®Google Scholar
• Egger SS, Drewe J, Schlienger RG. Potential drug-drug interactions in the medication of medical patients at hospital discharge. Eur J Clin Pharmacol 2003;58(11):773-8
   PubMed Web of Science ®Google Scholar
• Herr RD, Caravati EM, Tyler LS, Prospective evaluation of adverse drug interactions in the emergency department. Ann Emerg Med 1992;21(11):1331-6
   PubMed Web of Science ®Google Scholar
• Becker ML, Kallewaard M, Caspers PW, Hospitalisations and emergency department visits due to drug-drug interactions: a literature review. Pharmacoepidemiol Drug Saf 2007;16:641-51
   PubMed Web of Science ®Google Scholar
• Riechelmann RP, Del Giglio A. Drug interactions in oncology: how common are they? Ann Oncol 2009;20:1907-12
   PubMed Web of Science ®Google Scholar
• Hamilton RA, Briceland LL, Andritz MH. Frequency of hospitalization after exposure to known drug-drug interactions in a Medicaid population. Pharmacotherapy 1998;18:1112-20
   PubMed Web of Science ®Google Scholar
• Davies EC, Green CF, Taylor S, Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One 2009;4:e4439
   PubMed Web of Science ®Google Scholar
• Sanchez Munoz-Torrero JF, Barquilla P, Velasco R, Adverse drug reactions in internal medicine units and associated risk factors. Eur J Clin Pharmacol 2010;66:1257-1264
   PubMed Web of Science ®Google Scholar
• Passarelli MC, Jacob-Filho W, Figueras A. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging 2005;22:767-77
   PubMed Web of Science ®Google Scholar
• Reis AM, De Bortoli Cassiani SH. Adverse drug events in an intensive care unit of a university hospital. Eur J Clin Pharmacol 2011; published online 19 January 2011; doi:10.1007/s00228-010-0987-y
   PubMedGoogle Scholar
• Thomas M, Boggs AA, DiPaula B, Siddiqi S. Adverse drug reactions in hospitalized psychiatric patients. Ann Pharmacother 2010;44:819-25
   PubMed Web of Science ®Google Scholar
• Tavassoli N, Sommet A, Lapeyre-Mestre M, Drug interactions with cholinesterase inhibitors: an analysis of the French pharmacovigilance database and a comparison of two national drug formularies (Vidal, British National Formulary). Drug Saf 2007;30:1063-71
   PubMed Web of Science ®Google Scholar
• Carleton BC, Smith MA, Gelin MN, Heathcote SC. Paediatric adverse drug reaction reporting: understanding and future directions. Can J Clin Pharmacol 2007;14:e45-57
   PubMedGoogle Scholar
• Leone R, Magro L, Moretti U, Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy. Drug Saf 2010;33:667-75
   PubMed Web of Science ®Google Scholar
• Strandell J, Wahlin S. Pharmacodynamic and pharmacokinetic drug interactions reported to VigiBase, the WHO global individual case safety report database. Eur J Clin Pharmacol 2011;67:633-41
   PubMed Web of Science ®Google Scholar
• Kraft WK, Waldman SA. Manufacturer's drug interaction and postmarketing adverse event data: what are appropriate uses? Drug Saf 2001;24:637-43
   PubMed Web of Science ®Google Scholar
• Wienkers LC, Heath TG. Predicting in vivo drug interactions from in vitro drug discovery data. Nat Rev Drug Discov 2005;4:825-33
   PubMed Web of Science ®Google Scholar
• Mathews DR, McNutt B, Okerholm R, Torsades de pointes occurring in association with terfenadine use. JAMA 1991;266:2375-6
   PubMed Web of Science ®Google Scholar
• Woosley RL, Chen Y, Freiman JP, Gillis RA. Mechanism of the cardiotoxic actions of terfenadine. JAMA 1993;269:1532-6
   PubMed Web of Science ®Google Scholar
• Magee CN, Medani SA, Leavey SF, Severe rhabdomyolysis as a consequence of the interaction of fusidic acid and atorvastatin. Am J Kidney Dis 2010;56:e11-15
   PubMed Web of Science ®Google Scholar
• Madadi P, Hildebrandt D, Gong IY, Fatal hydrocodone overdose in a child: pharmacogenetics and drug interactions. Pediatrics 2010;126:e986-9
   PubMed Web of Science ®Google Scholar
• Moling O, Rimenti G, Pristera R, Fatal lactic acidosis precipitated by nifedipine in a patient treated with disulfiram and antiretrovirals. Drug Metab Lett 2009;3:176-80
   PubMedGoogle Scholar
• Ratz Bravo AE, Hofer S, Krahenbuhl S, Ludwig C. Fatal drug-drug interaction of brivudine and capecitabine. Acta Oncol 2009;48:631-3
   PubMed Web of Science ®Google Scholar
• Juntti-Patinen L, Neuvonen PJ. Drug-related deaths in a university central hospital. Eur J Clin Pharmacol 2002;58:479-82
   PubMed Web of Science ®Google Scholar
• Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 2008;168:1890-6
   PubMed Web of Science ®Google Scholar
• Viktil KK, Blix HS, Moger TA, Reikvam A. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 2007;63:187-95
   PubMed Web of Science ®Google Scholar
• Nguyen JK, Fouts MM, Kotabe SE, Lo E. Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. Am J Geriatr Pharmacother 2006;4:36-41
   PubMedGoogle Scholar
• May FE, Stewart RB, Cluff LE. Drug interactions and multiple drug administration. Clin Pharmacol Ther 1977;22:322-8
   PubMed Web of Science ®Google Scholar
• Goldberg RM, Mabee J, Chan L, Wong S. Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population. Am J Emerg Med 1996;14:447-50
   PubMed Web of Science ®Google Scholar
• Hovstadius B, Hovstadius K, Astrand B, Petersson G. Increasing polypharmacy - an individual-based study of the Swedish population 2005-2008. BMC Clin Pharmacol 2010;10:16
   PubMedGoogle Scholar
• Gurwitz JH. Polypharmacy: a new paradigm for quality drug therapy in the elderly? Arch Intern Med 2004;164:1957-9
   PubMed Web of Science ®Google Scholar
• Munger MA. Polypharmacy and combination therapy in the management of hypertension in elderly patients with co-morbid diabetes mellitus. Drugs Aging 2010;27:871-83
   PubMed Web of Science ®Google Scholar
• Haider SI, Johnell K, Thorslund M, Fastbom J. Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992 - 2002. Int J Clin Pharmacol Ther 2007;45:643-53
   PubMed Web of Science ®Google Scholar
• Becker ML, Visser LE, van Gelder T, Increasing exposure to drug-drug interactions between 1992 and 2005 in people aged > or = 55 years. Drugs Aging 2008;25:145-52
   PubMed Web of Science ®Google Scholar
• Gupta S, Rappaport HM, Bennett LT. Polypharmacy among nursing home geriatric Medicaid recipients. Ann Pharmacother 1996;30:946-50
   PubMed Web of Science ®Google Scholar
• Tamblyn RM, McLeod PJ, Abrahamowicz M, Laprise R. Do too many cooks spoil the broth? Multiple physician involvement in medical management of elderly patients and potentially inappropriate drug combinations. CMAJ 1996;154:1177-84
   PubMed Web of Science ®Google Scholar
• Bedell SE, Jabbour S, Goldberg R, Discrepancies in the use of medications: their extent and predictors in an outpatient practice. Arch Intern Med 2000;160:2129-34
   PubMed Web of Science ®Google Scholar
• Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007;5:345-51
   PubMedGoogle Scholar
• Kaufman DW, Kelly JP, Rosenberg L, Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002;287:337-44
   PubMed Web of Science ®Google Scholar
• Fialova D, Topinkova E, Gambassi G, Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005;293:1348-58
   PubMed Web of Science ®Google Scholar
• Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet 2007;370:185-91
   PubMed Web of Science ®Google Scholar
• Hohl CM, Dankoff J, Colacone A, Afilalo M. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med 2001;38:666-71
   PubMed Web of Science ®Google Scholar
• Tulner LR, Frankfort SV, Gijsen GJ, Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance. Drugs Aging 2008;25:343-55
   PubMed Web of Science ®Google Scholar
• Ament PW, Bertolino JG, Liszewski JL. Clinically significant drug interactions. Am Fam Physician 2000;61:1745-54
   PubMed Web of Science ®Google Scholar
• Regal RE, Ong Vue C. Drug interactions between antibiotics and selected maintenance medications: seeing more clearly through the narrow therapeutic window of opportunity. Consult Pharm 2004;19:1119-28
   PubMedGoogle Scholar
• De Leon J, Armstrong SC, Cozza KL. The dosing of atypical antipsychotics. Psychosomatics 2005;46:262-73
   PubMed Web of Science ®Google Scholar
• Wilting I, Movig KL, Moolenaar M, Drug-drug interactions as a determinant of elevated lithium serum levels in daily clinical practice. Bipolar Disord 2005;7:274-80
   PubMed Web of Science ®Google Scholar
• Ansari JA. Drug interactions and pharmacist. J Young Pharm 2010;2:326-31
   PubMedGoogle Scholar
• Tyler T. Drug interactions in metastatic breast cancer. J Oncol Pharm Pract 2010; published online 22 September 2010; doi: 10.1177/1078155210379167
   Google Scholar
• Ma TK, Lam YY, Tan VP, Yan BP. Variability in response to clopidogrel: how important are pharmacogenetics and drug interactions? Br J Clin Pharmacol 2011; published online 25 February 2011; doi: 10.1111/j.1365-2125.2011.03949.x.
   PubMed Web of Science ®Google Scholar
• Gasche Y, Daali Y, Fathi M, Codeine intoxication associated with ultrarapid CYP2D6 metabolism. N Engl J Med 2004;351:2827-31
   PubMed Web of Science ®Google Scholar
• Mikus G, Schowel V, Drzewinska M, Potent cytochrome P450 2C19 genotype-related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir. Clin Pharmacol Ther 2006;80:126-35
   PubMed Web of Science ®Google Scholar
• Seymour RM, Routledge PA. Important drug-drug interactions in the elderly. Drugs Aging 1998;12:485-94
   PubMed Web of Science ®Google Scholar
• Bates ER, Lau WC, Angiolillo DJ. Clopidogrel-drug interactions. J Am Coll Cardiol 2011;57:1251-63
   PubMed Web of Science ®Google Scholar
• Tirkkonen T, Laine K. Drug interactions with the potential to prevent prodrug activation as a common source of irrational prescribing in hospital inpatients. Clin Pharmacol Ther 2004;76:639-47
   PubMed Web of Science ®Google Scholar
• Klein TE, Chang JT, Cho MK, Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenetics Research Network and Knowledge Base. Pharmacogenomics J 2001;1:167-70
   PubMedGoogle Scholar
• Mega JL, Close SL, Wiviott SD, Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med 2009;360:354-62
   PubMed Web of Science ®Google Scholar
• FDA. Early communication about on ongoing safety review of clopidogrel bisulfate (marketed as Plavix) (26 January 2009). Available from: http://www.fda.gov/drugs/drugsafety/postmarketdrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm079520.htm [Last accessed 17 May 2011]
   Google Scholar
• EMEA. Public Statement on Possible Interaction Between Clopidogrel and Proton Pump Inhibitors (29 May 2009). Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Public_statement/2009/11/WC500014409.pdf [Accessed 4 May 2011]
   Google Scholar
• Gerhard T. Clopidogrel and proton pump inhibitors: a clinically meaningful interaction? Pharmacoepidemiol Drug Saf 2011;20:214-18
   PubMed Web of Science ®Google Scholar
• Fontes-Carvalho R, Albuquerque A, Araujo C, Omeprazole, but not pantoprazole, reduces the antiplatelet effect of clopidogrel: a randomized clinical crossover trial in patients after myocardial infarction evaluating the clopidogrel-PPIs drug interaction. Eur J Gastroenterol Hepatol 2011;23:396-404
   PubMed Web of Science ®Google Scholar
• Backstrom M, Ekman E, Mjorndal T. Adverse drug reaction reporting by nurses in Sweden. Eur J Clin Pharmacol 2007;63:613-18
   PubMed Web of Science ®Google Scholar
• Ekman E, Backstrom M. Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden. Eur J Clin Pharmacol 2009;65:43-6
   PubMed Web of Science ®Google Scholar
• Smithburger PL, Buckley MS, Bejian S, A critical evaluation of clinical decision support for the detection of drug-drug interactions. Expert Opin Drug Saf 2011; published online 4 May 2011; doi:10.1517/14740338.2011.583916
   PubMed Web of Science ®Google Scholar
• Bertsche T, Pfaff J, Schiller P, Prevention of adverse drug reactions in intensive care patients by personal intervention based on an electronic clinical decision support system. Intensive Care Med 2010;36:665-72
   PubMed Web of Science ®Google Scholar
• Hatton RC, Rosenberg AF, Morris CT, Evaluation of contraindicated drug-drug interaction alerts in a hospital setting. Ann Pharmacother 2011;45:297-308
   PubMed Web of Science ®Google Scholar
• Saverno KR, Hines LE, Warholak TL, Ability of pharmacy clinical decision-support software to alert users about clinically important drug-drug interactions. J Am Med Inform Assoc 2011;18:32-7
   PubMed Web of Science ®Google Scholar
• Ma Q, Lu AY. Pharmacogenetics, pharmacogenomics, and individualized medicine. Pharmacol Rev 2011;63:437-59
   PubMed Web of Science ®Google Scholar